Skip to main content
logo
ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)
China flag China · Delayed Price · Currency is CNY
10.58
+0.17 (1.63%)
Sep 30, 2025, 3:04 PM CST

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Urinary System Drugs
198.17M
Log In
Log In
Log In
Log In
Upgrade
Urinary System Drugs Growth
20.06%
Log In
Log In
Log In
Log In
Upgrade
Anti-infective Drugs
166.45M
Log In
Log In
Log In
Log In
Upgrade
Anti-infective Drugs Growth
-6.15%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Raw Materials and Intermediates
80.41M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Raw Materials and Intermediates Growth
41.63%
Log In
Log In
Log In
Log In
Upgrade
Smoking Cessation Drugs
64.16M
Log In
Log In
Log In
Log In
Upgrade
Children's Drugs
60.80M
Log In
Log In
Log In
Log In
Upgrade
Children's Drugs Growth
-9.47%
Log In
Log In
Log In
Log In
Upgrade
Respiratory System Drugs
60.48M
Log In
Log In
Log In
Log In
Upgrade
Respiratory System Drugs Growth
4.57%
Log In
Log In
Log In
Log In
Upgrade
Other Drugs
60.06M
Log In
Log In
Log In
Log In
Upgrade
Other Drugs Growth
-55.72%
Log In
Log In
Log In
Log In
Upgrade
Antidepressants
56.25M
Log In
Log In
Log In
Log In
Upgrade
Anti-allergic Drugs
46.75M
Log In
Log In
Log In
Log In
Upgrade
Anti-allergic Drugs Growth
-29.34%
Log In
Log In
Log In
Log In
Upgrade
Other
53.05M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
162.34%
Log In
Log In
Log In
Log In
Upgrade
Service
-
Log In
Log In
Log In
Log In
Upgrade
Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Kidney Disease Drugs
-
Log In
Log In
Log In
Log In
Upgrade
Kidney Disease Drugs Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
China
846.43M
Log In
Log In
Log In
Log In
Upgrade
China Growth
5.92%
Log In
Log In
Log In
Log In
Upgrade
Overseas
172.99K
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
-15.05%
Log In
Log In
Log In
Log In
Upgrade